In cell-based assays, endotoxins trigger Toll-like receptor 4 (TLR4), leading to the release of pro-inflammatory cytokines. These cytokines can mask the actual biological effect of your drug candidate.
Endotoxins are structural components located in the outer membrane of gram-negative bacteria such as E. coli. During the production of biologics (e.g., proteins, antibodies, plasmid DNA, and vaccines), bacterial lysis inevitably releases these molecules into the medium. The presence of these contaminants is a critical hurdle. Even at picogram levels, endotoxins are highly potent, interacting with mammalian immune receptors to induce inflammatory cascades. Our endotoxin removal service helps you obtain high-quality proteins, antibodies and DNA by reducing pyrogen levels to below 0.01 EU/mg through advanced phase separation, affinity chromatography, and proprietary detergent-polishing techniques. Creative Biolabs ensures your biologics meet the strictest regulatory standards for safety and efficacy.
Fig.1 The Structure of bacterial endotoxin.1
The removal of endotoxins is a non-negotiable requirement for any biological products intended for in vitro cell assays or in vivo administration. It is a critical safeguard for both experimental integrity and clinical safety.
In cell-based assays, endotoxins trigger Toll-like receptor 4 (TLR4), leading to the release of pro-inflammatory cytokines. These cytokines can mask the actual biological effect of your drug candidate.
In preclinical studies, endotoxins act as potent pyrogens. High levels can cause fever, hypotension, and septic shock in animal models, compromising the ethical and scientific validity of the study.
Global pharmacopeias set strict limits (< 5 EU/kg) for injectable biologics. Failure to meet these thresholds during the development phase can lead to significant delays in clinical trial approvals.
Endotoxins can sometimes interact with the target protein, leading to aggregation or reduced shelf-life.
Fig.2 The immune response to bacterial endotoxin regarding homeostasis.1
Creative Biolabs provides a specialized, expert-led endotoxin removal service designed to eliminate pyrogenic contaminants from critical biologics. We provide a multi-modal technology platform to address diverse purification challenges.
This method is exceptionally effective for hydrophilic proteins. We sequester the hydrophobic lipid A into a detergent phase by changing temperature and achieve a sample with low endotoxin levels.
We utilize high-resolution anion-exchange resins to trap endotoxins with the strong negative charge while allowing your target protein to elute cleanly.
We employ specialized ligands which specifically target the lipid A moiety. This method is the gold standard for high-value antibodies and enzymes.
We withdraw endotoxin complexes from solution through complex coacervation utilizing polycationic network sorbents.
For buffer exchange and the removal of large LPS micelles, we utilize high-performance membranes with specific molecular weight cut-offs to ensure initial clearance.
Our endotoxin removal service is a highly structured, data-driven process designed to bridge the gap between initial protein expression and clinical-grade purity. Our workflow is designed for transparency and reproducibility, ensuring every client understands the path to purity.
With over 20 years of experience at the forefront of biopurification, Creative Biolabs provides the technical depth required to handle the most complex molecular profiles. We stand at the forefront of bioprocessing through several distinct service features.
With a focus on high recovery, structural integrity, and validated results, we help researchers and biopharma companies transition from the lab to the clinic with absolute confidence in their product purity. Contact us about your needs.
Reference